LECHI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 7.172
EU - Europa 5.658
AS - Asia 2.703
SA - Sud America 109
AF - Africa 12
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.669
Nazione #
US - Stati Uniti d'America 7.144
GB - Regno Unito 2.353
CN - Cina 1.765
SG - Singapore 825
SE - Svezia 735
FI - Finlandia 488
FR - Francia 429
RU - Federazione Russa 418
IE - Irlanda 399
DE - Germania 306
IT - Italia 265
UA - Ucraina 172
BR - Brasile 91
BE - Belgio 35
TR - Turchia 21
CA - Canada 17
IN - India 11
NL - Olanda 11
CH - Svizzera 10
AU - Australia 9
IL - Israele 9
VN - Vietnam 9
IR - Iran 8
KR - Corea 8
CL - Cile 6
BG - Bulgaria 5
EU - Europa 5
MA - Marocco 5
BD - Bangladesh 4
HK - Hong Kong 4
MX - Messico 4
SA - Arabia Saudita 4
AR - Argentina 3
CZ - Repubblica Ceca 3
ES - Italia 3
ID - Indonesia 3
IQ - Iraq 3
JM - Giamaica 3
LV - Lettonia 3
PA - Panama 3
PE - Perù 3
PK - Pakistan 3
RO - Romania 3
RS - Serbia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CO - Colombia 2
HU - Ungheria 2
JP - Giappone 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
MU - Mauritius 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
PL - Polonia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NG - Nigeria 1
OM - Oman 1
PY - Paraguay 1
SC - Seychelles 1
SL - Sierra Leone 1
SR - Suriname 1
TJ - Tagikistan 1
ZA - Sudafrica 1
Totale 15.669
Città #
Southend 1.979
Jacksonville 1.697
Chandler 1.129
Woodbridge 743
Singapore 633
Ann Arbor 592
Dublin 399
Houston 384
Ashburn 368
Wilmington 222
Jinan 214
Lawrence 186
Princeton 186
Nanjing 174
Beijing 164
Shenyang 142
New York 130
Helsinki 129
Hebei 101
Boardman 90
Zhengzhou 79
Changsha 76
Tianjin 74
Verona 71
Ningbo 68
Philadelphia 64
Falls Church 62
Nanchang 59
Haikou 55
Fairfield 54
Taizhou 51
Milan 50
Jiaxing 48
Guangzhou 43
Sindelfingen 43
Seattle 41
Hangzhou 39
Taiyuan 39
Norwalk 37
Brussels 35
Cambridge 31
Lancaster 30
Lanzhou 29
Fuzhou 28
Los Angeles 27
Auburn Hills 24
Redmond 20
Santa Clara 19
Dallas 18
Düsseldorf 17
Rome 17
Washington 14
Detroit 12
Kent 12
Munich 11
San Francisco 11
London 10
Phoenix 10
São Paulo 10
Clearwater 9
Chicago 8
San Mateo 8
Toronto 8
San Diego 7
Dong Ket 6
Falkenstein 6
Moscow 6
Padova 6
Redwood City 6
Rio de Janeiro 6
Seoul 6
Tappahannock 6
Ardabil 5
Belo Horizonte 5
Bologna 5
Brasília 5
Palermo 5
Perugia 5
Pisa 5
Tel Aviv 5
Augusta 4
Enterprise 4
Genoa 4
Kemerovo 4
Sofia 4
Zurich 4
Bari 3
Belgrade 3
Curitiba 3
Dearborn 3
Dhaka 3
Dongguan 3
Florence 3
Frankfurt am Main 3
Lima 3
Madrid 3
Melbourne 3
Monmouth Junction 3
Mumbai 3
Palomonte 3
Totale 11.294
Nome #
Le medicine complementari. Definizioni, applicazioni, evidenze scientifiche disponibili 149
Pseudomonas septicaemia. A review of 60 cases observed in a university hospital 147
The F2-isoprostane 8-epi-prostaglandin F2alpha increases platelet adhesion and expression of adhesion molecules 141
Collagen gene expression and proliferation rate of skin fibroblasts hypertensive subjects 138
[Peripheral insulin resistance and free intralymphocyte magnesium and calcium concentrations in patients with essential hypertension] 135
Platelet intracellular free Ca2+ after incubation with plasma from hypertensive patients 130
[The effect of dopaminergic stimulation and inhibition on the urinary excretion of aldosterone and kallikrein in spontaneously hypertensive rats] 129
Urinary 6-keto-PGF1 alpha after captopril and indomethacin: possible contribution of PGI2 to the antihypertensive mechanism of ACE inhibitors 126
Oxidized low density lipoprotein (LDL) and platelet intracellular calcium: Interaction with nitric oxide 126
Increased sodium-lithium countertransport in red cells of patients with Bartter's syndrome 124
A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels 124
Endothelial progenitor cells in patients with essential hypertension. 124
Activity of cardiopulmonary baroreceptors, peripheral resistance and cutaneous microcirculation in patients with peripheral obstructive arterial disease. 123
Altered excretion of prostaglandin and thromboxane metabolites in pregnancy induced hypertension. 121
Carbenoxolone and prostaglandin E2 and F2 alpha gastric juice levels in man 118
Efficacy of ketanserin in the therapy of Raynaud's phenomenon: thermometric data 117
Acute hyperhomocysteinemia induces a reduction in arterial distensibility and compliance 117
Antihypertensive activity of enalapril. Effect of ibuprofen and different salt intakes 116
Correlations between plasma levels of an endogenous digitalis-like substance and haemodynamic parameters measured during cardiac catheterization 116
Diagnostic value and biological significance of antibody-coated bacteria in urine 115
Modificazioni della flow-motion del microcircolo cutaneo indotte da iloprost in pazienti affetti da sclerodermia. 113
Elevated plasma fibrinogen levels in patients with essential hypertension are related to vascular complications. 112
Erythrocyte Na(+)-H+ exchange activity in essential hypertensive and obese patients: role of excess body weight 111
Vascular adhesion molecule-1 and markers of platelet function before and after a treatment with iloprost or a supervised physical exercise program in patients with peripheral arterial disease. 111
Pharmacokinetics of ceftazidime and ceftriaxone and their penetration into the ascitic fluid 110
Urinary kallikrein excretion in Bartter's syndrome 108
Vasculopatici sottoposti ad esercizio fisico allenante: nitriti/nitrati ed adesività piastinica 108
243. Analisi della variabilità della frequenza cardiaca ed emodinamica periferica in corso di stimolo dei barocettori cardiopolmonari in soggetti fumatori. 108
Oxidized Lipids and platelet activation: interaction with Nitric Oxide 108
Erythrocyte Na(+)-H+ exchange activity in a group of essential hypertensive patients 107
Effetti del vino rosso sulla funzione endoteliale microcircolatoria e sull'emodinamica dell'avambraccio in soggetti sani. Dati preliminari. 107
8-Iso-PGF2 alpha induces beta 2-integrin-mediated rapid adhesion of human polymorphonuclear neutrophils: a link between oxidative stress and ischemia/reperfusion injury. 107
Contribution of four markers of tubular proteinuria in detecting upper urinary tract infections. A multivariate analysis 106
NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes. 106
Defibrotide and peripheral obliterative arterial disease: preliminary data 105
Erythrocyte Na(+)-H+ exchanger and Na(+)-Li+ countertransport activity in primary aldosteronism 104
Oxidized LDL and intracellular calcium: interaction with nitric oxide. 104
NCX4016 (NO-aspirin) inhibits thromboxane biosynthesis and tissue factor expression and activity in human monocytes. 104
Increased basal and thrombin-induced free calcium in platelets of essential hypertensive patients 103
Increase in plasma digitalis-like activity during percutaneous transluminal coronary angioplasty in patients with coronary stenosis 103
Patients with vascular disease undergoing training physical exercise: urinary nitrites/nitrates and platelets adhesivenes 103
Comparative efficacy of ketanserin and pentoxiphylline in treatment of Raynaud's phenomenon 102
Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition 102
[Considerations on the bacterial flora in patients with infections of the respiratory tract and in immunosuppressed patients (author's transl)] 101
Urinary and kidney kallikrein in hypertensive rats 101
Collagen I and III mRNA gene expression and cell growth potential of skin fibroblasts in patients with essential hypertension. 100
Increased urinary 6-keto-PGF1 alpha excretion during water immersion is blunted by metoclopramide in normal man. 99
Antiaggregating and vasodilatory effects of a new nitroderivative of acetylsalicylic acid 99
Endothelial dysfunction in mitochondrial diseases: biological and biochemical evidence of increased oxidative stress and peroxinitrite generation 99
Effects of long-term nicardipine treatment on hemodynamics of large arteries in essential hypertension 98
The kinetics of cefuroxime in ascitic and pleural fluid 98
Ceftazidime in patients with severe Pseudomonas infections 98
High plasma levels of a ouabain-like factor in normal pregnancy and in pre-eclampsia 98
Endothelial dysfunction and increased oxidative stress in mitochondrial diseases. 98
Evolution of carotid atheromatous lesions in endarterectomized patients 97
Reduction of the antihypertensive effect of captopril induced by prostaglandin synthetase inhibition 97
Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress. 97
Hepatitis vaccination among drug users. 97
Distribution of ceftazidime in ascitic fluid 95
Twenty-four hour desferrioxamine test in normal, iron deficient and hypersideraemic (both hypersiderotic and non-hypersiderotic) subjects 95
Reduced platelet adhesion and expression of adhesion molecules after treatment with iloprost in pheripheral artery disease 95
Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement. 95
Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism 94
[Behaviour of urinary excretion of lysozyme in renal diseases and in urinary tract infections (author's transl)] 94
Haemodynamic parameters in hypertensive patients: changes induced by lacidipine and nifedipine 93
Increased leukocyte aggregation in patients with hypercholesterolaemia 93
Plasma ouabain-like activity in essential hypertensive patients and in subjects with primary aldosteronism 92
Kinetics of bumetanide-sensitive Na+-K+ co-transport in erythrocytes of essential hypertensive patients 91
Impaired ammonia metabolism in severe hepatic disease 91
[Changes of the pressoactive substance extractable from both kidneys of rats with hypertension induced by complete ligation of the aorta between the renal arteries] 91
Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte-platelet aggregates 91
Valutazione ecografica (Duplex Scanner) della carotide extracranica in pazienti sottoposti ad intervento di endoarteriectomia 91
[Effect of indomethacin on the plasma renin activity in patients with arterial hypertension] 90
Somministrazione di acido ascorbico e modificazioni del flusso macro e micro-circolatorio in soggetti sottoposti a carico orale di glucosio. Dati preliminari. 90
Determinants of platelet activation in human essential hypertension 90
Inhibition of TF expression on activated monocytes: potential role in the anti-thrombotic activity of NCX-4016 90
[Behavior of the urinary excretion of kallikrein in normal subjects after oral water overloading] 89
Prevalence of morphological alterations in cervical vessels: A colour duplex ultrasonographic study in a series of 3300 subjects 89
No positive tests for syphilis in 6 years of observation among heroin drug users in north-eastern Italy. 89
Intralymphocyte free magnesium and cardiac anatomy and function in a group of patients with essential hyepertension 88
Effect of glutathione infusion of leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial. 87
Free calcium concentration in platelets of patients with essential hypertension 86
Ketoconazole: clinical evaluation in severe fungal infections 86
[Results of the use of a new aminoglycoside antibiotic, sisomicin, in gram negative bacterial respiratory infections] 86
In vitro study of antiaggregating activity of two nitroderivative of acetylsalicylic acid. 86
A Variant Upstream of the CDH13 Adiponectin Receptor Gene and Metabolic Syndrome in Swedes. 86
Oxidized LDL and reduction of the antiaggregating activity of nitric oxide derived from endothelial cells 85
Haemodynamic effects of eprosartan and valsartan in hypertensive patients during isometric and mental stress. 85
Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease. 85
NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. 85
Ambulatory blood pressure phenotypes are more heritable than office blood pressure phenotypes. 85
[Clinical evaluation of metolazone in edematogenic syndromes] 84
Beta2 integrin-dependent neutrophil adhesion induced by minimally modified low-density lipoproteins is mainly mediated by F2-isoprostanes. 84
Oxidized LDL and platelet aggegation: interaction with nitric oxide. 83
Angiotensin-Converting Enzyme genotype and Endothelium-Dependent Vasodilation of Conduit Arteries and Forearm Microcirculation in Humans 83
Effects of smoking on cardiopulmonary baroreceptor activation and peripheral vascular resistance. 83
The F2-Isoprostane 8-Epiprostaglandin F2-alpha Increase Platele Adhesion and Reduces the Antiadhesive and Antiaggregatory Effects of NO. 83
[Frequency and antibiotic sensitivity of gram-negative bacteria in urinary tract infections in relation to predisposing factors (author's transl)] 82
Angiotensin converting enzyme inhibitors improve endothelial function in type I (insulin-dependent) diabetic patients with normal arterial pressure and microalbuminuria 82
Erythrocyte Na+-H+ exchanger kinetics and Na+-Li+ countertransport activity in essential hypertensive patients. 82
Totale 10.169
Categoria #
all - tutte 50.997
article - articoli 44.799
book - libri 1.313
conference - conferenze 4.013
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 872
Totale 101.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.414 0 0 0 0 0 256 180 195 92 215 61 415
2020/20212.127 210 263 119 266 221 261 22 184 194 16 282 89
2021/20221.604 147 474 8 161 53 78 28 89 74 46 106 340
2022/20233.103 237 307 277 525 353 685 45 206 342 16 79 31
2023/20241.241 71 124 89 173 153 212 24 62 12 50 162 109
2024/20251.609 215 260 98 611 327 98 0 0 0 0 0 0
Totale 15.756